New cord blood technique aims to save lives in High-Risk blood cancers
NCT ID NCT03913026
Summary
This study is testing a new method for cord blood transplants in adults with high-risk forms of leukemia and myelodysplasia, where standard transplants often fail. The method uses a molecule called UM171 to expand the number of stem cells in a single cord blood unit before transplant. The goal is to improve survival, speed up recovery, and reduce serious complications like graft-versus-host disease compared to standard cord blood transplants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CIUSSS de l'Est-de-l'île-de Montreal, Hôpital Maisonneuve-Rosemont
Montreal, Quebec, H1T2M4, Canada
Conditions
Explore the condition pages connected to this study.